Analysts: Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

3,460JPY
2:00am EDT
Price Change (% chg)

¥-30 (-0.86%)
Prev Close
¥3,490
Open
¥3,495
Day's High
¥3,510
Day's Low
¥3,415
Volume
1,112,700
Avg. Vol
959,977
52-wk High
¥3,510
52-wk Low
¥1,910

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 31 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 7 8 8 9
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.54 2.54 2.57

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-14 12 458,592.00 468,000.00 447,500.00 436,418.00
Year Ending Dec-15 12 489,742.00 515,000.00 471,000.00 466,210.00
Earnings (per share)
Year Ending Dec-14 13 92.43 103.00 83.50 100.13
Year Ending Dec-15 13 111.46 128.55 104.06 113.73
LT Growth Rate (%) 4 8.93 11.40 6.00 7.57

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 100,000.00 124,045.00 24,045.00 24.05
Quarter Ending Dec-13 117,300.00 117,119.00 181.00 0.15
Quarter Ending Sep-13 100,100.00 105,517.00 5,417.00 5.41
Quarter Ending Jun-13 101,600.00 110,600.00 9,000.00 8.86
Quarter Ending Mar-13 92,350.00 90,416.00 1,934.00 2.09

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-14 458,592.00 456,800.00 455,333.00 455,550.00 436,418.00
Year Ending Dec-15 489,742.00 486,450.00 487,008.00 487,730.00 466,210.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-14 2 1 4 1
Year Ending Dec-15 2 1 3 2
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks